TrialDiabetes, obesity & metabolism2013

Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.

J Rosenstock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.